Rankings
▼
Calendar
MDGL Q1 2016 Earnings — Madrigal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
MDGL
Madrigal Pharmaceuticals, Inc.
$10B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$7M
EPS (Diluted)
$-9.72
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$448,000
Balance Sheet
Total Assets
$53M
Total Liabilities
$9M
Stockholders' Equity
$44M
Cash & Equivalents
$43M
← FY 2016
All Quarters
Q2 2016 →
